Abstract:Aim: To construct a vector expressing through target gene given by human telomerase reserve transcriptase (hTERT) promoter with pLHCX as vector and realize target expression. Methods: Experiments were performed at the Key Laboratory of Molecular Medicine from September 2005 to May 2006. 1 The phTERT-luc plasmid containing 319 bp hTERT core promoter was presented by Dr. Zheng from Military Academy of Science; Retrovirus vector pLHCX was presented by Professor Zhu from Zhejiang University; The plasmid pCMV-Neo-BamH-wtp53 containing 1.8 kb wtp53 gene was presented by Professor Zhu from Second Military Medical University of Chinese PLA; Enhanced green fluorescent protein report plasmid pEGFP-N2 and pEGFP-C1 were kept in this laboratory; human carcinoma of large intestine cell strain SW620 and HT-29, human cervical carcinoma cell strain Hela, human lung carcinoma cell strain A549, and human lung embryo fibroblast MRC-5 were kept in this laboratory. 2 The plasmid pLHCX-hTERT-EGFP expressing EGFP driven by hTERT promoter and the plasmid pLHCX-hTERT-wtp53 expressing wtp53 also driven by hTERT promoter were constructed through directional cloning. The plasmid pLHCX-hTERT-EGFP and the plasmid pLHCX-CMV-EGFP were used for the transfection of human carcinoma of large intestine cell strain SW620 and HT-29, human cervical carcinoma cell strain Hela, human lung carcinoma cell strain A549, and human lung embryo fibroblast MRC-5. 3 The flow cytometer was used to analyze the transfection efficiency of pLHCX-hTERT-EGFP so as to declare the HTERT promoter specific expression in tumor cells. The human colon cancer cell line SW620, which the p53 gene is mutation, were infected with the plasmid pLHCX-hTERT-wtp53 and p53 mRNA, p53 protein were demonstrated with RT-PCR and Western blot. The normal human embryo lung fibroblast cell strain MRC-5 and the human colon cancer cell line SW620 and HT-29 were treated with the plasmid pLHCX-hTERT-wtps3, the propagate inhibition and apoptosis of cells were detected by MTT' and FCM, respectively. Results: 1 The plasmids pLHCX-hTERT-EGFP and pLHCX-hTERT-wtp53 were successfully constructed, which were confirmed by restriction endonuclease and sequencing. Green fluorescent protein expression was observed by pLHCX-hTERT-EGFP transfection SW620. The sequencing verified that complete wtp53 fragment was found. 2 Flow cytometry declared that enhanced green fluorescent protein expression was significantly higher in the SW620, Hela and A549 than the MRC-5 after pLHCX-hTERT-EGFP treatment (P < 0.05), but no significant difference was found in positive and negative cells above mentioned (P > 0.05). 3 The expression of wtp53 mRNA and the protein were demonstrated by RT-PCR and Western blot, respectively. 4 MTT showed that recombinant plasmid had significant inhibition on carcinoma of large intestine with positive telomerase, but had no significant effects on MRC-5 cells with negative telomerase (P < 0.05). 5 Flow cytometry showed that the apoptosis of carcinoma of large intestine with positive telomerase was significantly higher than the MRC-5 cells with negative telomerase induced by recombinant plasmid (P < 0.05). Conclusion: The retroviral vector pLHCX-hTERT-EGFP can express in tumor cells specifically and the retroviral vector pLHCX-hTERT-wtp53 can affect carcinoma of large intestine with positive telomerase specifically.

Construction of recombinant plasmid containing hTERT promoter and PE38KDEL gene and its anti-apoptosis effect on human pancreatic cancer cell MiaPaCa2

Construction and identification of PE38KDEL gene vector under the regulation of hTERT promoter

[Activity of the TNF-related Apoptosis-Inducing Ligand Gene Expressed from the Htert Promoter on Colon Cancer Cell Line HT-29].

[Construction of Mirna Expression Vector Dual-Targeting on HIF-1α/survivin Genes and Its Effects on Proliferation of Pancreatic Cancer Panc-1 Cell Line].

Construction of Recombinant Adenovirus Containing P53 Up-Regulated Modulator of Apoptosis and Its Effect on Pancreatic Cancer in Vitro and in Vivo

Htert-Targeted E. Coli Purine Nucleoside Phosphorylase Gene/6-Methylpurine Deoxyribose Therapy for Pancreatic Cancer.

Construction and identification of human telomerase reverse transcriptase-targeted small hairpin RNA-expressing plasmid

Construction of Targeted Plasmid Vector Pcdna3.1-Egr.1p-p16 and Its Expression in Pancreatic Cancer JF305 Cells Induced by Radiation in Vitro.

Construction of Two Different Recombinant Plasmids Containing Human Telomerase Reverse Transcriptase Gene Promoter

Construction and identification of eukaryotic expression plasmid carrying hTERT-P2A-EGFP

Construction of hTERT promoter-driven TRAIL expression vector and its inhibitory effects on hepatoma cell proliferation

Construction of retroviral vector expressing wild type p53 gene driven by hTERT promoter firstly by retrovirus only infecting dividing cells

[Expression of Modified Humanized Immunoapoptotic Protein and Its Specific Killing Effect on HER2-positive Tumor Cells].

Construction of an Expression Vector Carrying Short Hairpin RNA Targeting Htert Gene and Its Effects on Breast Cancer Cell Telomerase Activity and Proliferation in Vivo

Construction of expression plasmid of the mutant PUMA and its expression in Hela cells

Construction of Recombinant Caspase-3 Eukaryotic Expression Plasmid and Its Expression Mediated by Vector Pcdna3.1(+) in Pancreatic Carcinoma Cells

Expression of p53-TAT fusion protein and its apoptosis-inducing activity on HepG 2 cells

hTERT/re-caspase-3 system induce apoptosis in hTERT-positive

Construction and expression of the vector of CD137L under the control of the hTERT promoter in human ovarian tumor cell lines

hTERT/re-caspase-3 system induce apoptosis in hTERT-positive cancer cells.

[Transcriptional Targeting Gene Therapy of Double Suicide Gene Driven by Htert Promoter in Hepatic Carcinoma].